Dabigatran affects thrombin-dependent platelet aggregation after a week-long therapy

Scandinavian Cardiovascular Journal : SCJ
Juraj SokolJan Stasko

Abstract

Dabigatran is a direct thrombin inhibitor. As the main adverse event is bleeding, it is relevant whether dabigatran has additional effects on platelet function. If so, it could affect the bleeding risk. We aimed to assess in vitro aggregation in patients with atrial fibrillation (AF) receiving dabigatran. We evaluated 32 AF patients treated with dabigatran (study group) and 18 non-anticoagulated non-AF blood donors (control group). We assessed light transmittance platelet aggregation (LTA) with 100 nmol/L γ-thrombin in both groups. The LTA was performed at two time-points in our dabigatran group of patients. The thrombin-induced platelet aggregation was significantly lower two hours after dabigatran was taken compared to baseline measurement (9% ± 6% vs. 29% ± 21%) in our study group. Moreover, we observed that the baseline value of platelet aggregation in patients on dabigatran treatment was significantly lower compared to healthy volunteers (29% ± 21% vs. 89 ± 8). However, one subanalysis showed that this significant reduction in platelet aggregation at baseline was only observed in patients who received dabigatran for over a week. The thrombin-induced platelet aggregation is reduced in non-valvular AF patients receiving dabi...Continue Reading

References

Mar 17, 1999·The Journal of Clinical Investigation·M L KahnS R Coughlin
Sep 9, 2005·The New England Journal of Medicine·Marcello Di NisioHarry R Büller
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Nov 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Zhenyu LiXiaoping Du
Jul 28, 2011·British Journal of Haematology·Paul HarrisonUNKNOWN British Committee for Standards in Haematology
Jul 16, 2014·Scandinavian Cardiovascular Journal : SCJ·Per WändellKristina Sundquist
Nov 28, 2015·Thrombosis Research·Christoph B OlivierMartin Moser
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Michael B StreiffJack Ansell
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Allison E BurnettJack Ansell
Jul 28, 2016·Scandinavian Cardiovascular Journal : SCJ·Per WändellKristina Sundquist
Jun 6, 2017·Journal of Thrombosis and Thrombolysis·Pernille Just VinholtMads Nybo
Jul 14, 2017·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Frantisek NehajMaros Mokan
Oct 11, 2017·Scandinavian Cardiovascular Journal : SCJ·Martin MaaroosJuha Hartikainen

❮ Previous
Next ❯

Citations

Feb 2, 2021·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Juraj SokolJan Stasko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.